Christine Schneckenleithner

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy.

Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy.

Journal: Blood
Published: October 13, 2017

A Kinase-Independent Function of CDK6 Links the Cell Cycle to Tumor Angiogenesis.

A Kinase-Independent Function of CDK6 Links the Cell Cycle to Tumor Angiogenesis.

Journal: Cancer cell
Published: August 10, 2016

Modeling BCR/ABL-driven malignancies in the mouse.

Modeling BCR/ABL-driven malignancies in the mouse.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: February 01, 2015

CDK6 as a key regulator of hematopoietic and leukemic stem cell activation.

CDK6 as a key regulator of hematopoietic and leukemic stem cell activation.

Journal: Blood
Published: October 25, 2014

Overexpression of primary microRNA 221/222 in acute myeloid leukemia.

Overexpression of primary microRNA 221/222 in acute myeloid leukemia.

Journal: BMC cancer
Published: February 07, 2013

A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis.

A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis.

Journal: Cancer cell
Published: November 23, 2012

Conditional Stat1 ablation reveals the importance of interferon signaling for immunity to Listeria monocytogenes infection.

Conditional Stat1 ablation reveals the importance of interferon signaling for immunity to Listeria monocytogenes infection.

Journal: PLoS pathogens
Published: January 10, 2012

Putting the brakes on mammary tumorigenesis: loss of STAT1 predisposes to intraepithelial neoplasias.

Putting the brakes on mammary tumorigenesis: loss of STAT1 predisposes to intraepithelial neoplasias.

Journal: Oncotarget
Published: December 22, 2011
Showing 1-8 of 8

Last Updated: 09/26/2026